INVESTOR CONTACT: Geoff O'BrienVice PresidentMediciNova, Inc.email@example.com
Akebia after the market close on Tuesday announced an expanded partnership with Japan's Otsuka Pharmaceuticals to develop and market its anemia pill Vadadustat in Europe, China and other territories.
MedicNova (MNOV) shares are climbing after its drug received fast track status from the Food and Drug Administration.
Let's look back at the stock performance of biotech companies issuing the worst, most pandering press releases from January 2014.
For the past three months, small-cap biotech stocks have been underperforming the broader market.